Research Topics
| Jane FreedmanSummaryAffiliation: Boston University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
CD40 ligand influences platelet release of reactive oxygen intermediatesSubrata Chakrabarti
The Whitaker Cardiovascular Institute, Evans Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Arterioscler Thromb Vasc Biol 25:2428-34. 2005..In this study, we examined the effect of sCD40L on platelet function and reactive oxygen and nitrogen species (RONS) generation...
Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart studyJane E Freedman
Department of Medicine, Boston University School of Medicine, Whitaker Cardiovascular Institute, 700 Albany St, W 507, Boston, MA 02118, USA
Circulation 122:119-29. 2010..Quantitative differences in the abundance of transcripts has been demonstrated in malignancies, but gene expression from a large community-based cohort examining risk of cardiovascular disease has never been reported...
The role of the blood transcriptome in innate inflammation and strokeJane E Freedman
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
Ann N Y Acad Sci 1207:41-5. 2010..By defining these changes, new insight into cerebrovascular disease and its therapeutics is being achieved...
Oxidative stress and plateletsJane E Freedman
Boston University School of Medicine, 715 Albany Street, W507, Boston, MA 02118, USA
Arterioscler Thromb Vasc Biol 28:s11-6. 2008....
Molecular regulation of platelet-dependent thrombosisJane E Freedman
Boston University School of Medicine, Whitaker Cardiovascular Institute, Boston, MA 02118, USA
Circulation 112:2725-34. 2005..However, this process is complex and influenced by a myriad of cellular and plasma-derived mediators that regulate the balance between occlusive and nonocclusive thrombosis...
Nitric oxide and its relationship to thrombotic disordersJ E Freedman
The Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, 715 Albany Street, W507, Boston, MA 02118, USA
J Thromb Haemost 1:1183-8. 2003..Diseases including atrial fibrillation and coronary atherothrombotic disease have been associated with impaired NO release or decrease in NO bioavailability...
The effect of dipyridamole on vascular cell-derived reactive oxygen speciesSubrata Chakrabarti
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, MA 02118, USA
J Pharmacol Exp Ther 315:494-500. 2005..These data suggest that the redox-dependent properties of dipyridamole have a direct effect on vascular cells...
Neutrophil CD40 enhances platelet-mediated inflammationPantila Vanichakarn
Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA
Thromb Res 122:346-58. 2008..While CD40 was recently reported to be present on neutrophils, the detailed mechanism of its interaction with platelets via CD40-CD40L has not been examined...
Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediatesOlga Vitseva
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
J Cardiovasc Pharmacol 46:445-51. 2005..These findings suggest potentially beneficial platelet-dependent antithrombotic and anti-inflammatory properties of purple grape-derived flavonoids...
Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule releaseSybille Rex
Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, 02118 MA, USA
Thromb Haemost 102:97-110. 2009..In summary, stimulation of platelets by either thrombotic or immune receptors leads to markedly different signalling responses and granular protein release consistent with differential contribution to coagulation and thrombosis...
Aspirin resistance: current conceptsPeter J Mason
Section of Cardiology, Boston University Medical Center, Boston, Massachusetts, USA
Rev Cardiovasc Med 5:156-63. 2004..The biological mechanisms, population prevalence, laboratory methods for detection, and clinical relevance of aspirin resistance are discussed in this review...
Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide releaseSubrata Chakrabarti
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, 715 Albany Street, W507, Boston, MA 02481, USA
Thromb Res 113:225-33. 2004..CONCLUSION: These observations suggest that the pharmacological effects of GPIIb/IIIa antagonists on platelet function, apart from inhibition of aggregation, may contribute to their efficacy...
Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effectsSubrata Chakrabarti
Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA
J Cardiovasc Pharmacol 50:449-57. 2007....
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinasePrice Blair
Whitaker Cardiovascular Institute, Evans Department of Medicine, Boston, MA 02118 2526, USA
Circ Res 104:346-54. 2009..This work substantiates the role of platelets in the immune and inflammatory response and suggests a mechanism by which bacteria could directly activate platelets...
Dipyridamole, cerebrovascular disease, and the vasculatureSubrata Chakrabarti
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA, 02118, USA
Vascul Pharmacol 48:143-9. 2008....
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular diseaseMuhammad Rizvi
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
Trends Mol Med 14:530-8. 2008..Understanding the roles and regulation of CD40-CD40L-mediated oxidative signaling in immune and non-immune cells could facilitate the development of therapeutics targeting diverse inflammatory diseases...
Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cellsSubrata Chakrabarti
Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA
Immunol Lett 122:170-84. 2009..In summary, we show that hypoxia can alter CD40-CD40L mediated endothelial-monocyte interaction, playing a significant role in vascular inflammation and cellular adhesion processes...
M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout miceSubrata Chakrabarti
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, 715 Albany Street, W507, Boston, MA 02118, USA
J Thromb Thrombolysis 28:394-400. 2009..In an animal model of vascular plaque, M118 is a potent inhibitor of arterial thrombosis and, despite lower in vivo anti-Xa and anti-IIa activity levels, M118 was superior to UFH in the prevention of arterial thrombosis...
The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytesLea M Beaulieu
Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, 700 Albany St, W507, Boston, MA 02118, USA
Thromb Res 125:205-9. 2010..Through TLRs, platelets go beyond hemostatic regulation and play a pivotal role in inflammation and infection...
The role of CD40L and VEGF in the modulation of angiogenesis and inflammationSubrata Chakrabarti
Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA
Vascul Pharmacol 53:130-7. 2010..Together, these studies reveal a new pathway by which VEGF-CD40L interactions can regulate the angiogenic and inflammatory process depending on the specific environment...
Review: Nutriceuticals as antithrombotic agentsSubrata Chakrabarti
Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA
Cardiovasc Ther 28:227-35. 2010..In addition, therapeutic opportunities in the area of nutragenomics and nutraceuticals in vascular and nonvascular diseases are also discussed...
CD40-40L signaling in vascular inflammationSubrata Chakrabarti
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
J Biol Chem 282:18307-17. 2007..Increased CD40L and MCP1 may contribute to the adherence of CD40-positive cells, such as platelets and monocytes, to the vessel wall modulating atherothrombosis...
The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediatesOlga Vitseva
Boston University School of Medicine, 715 Albany St, W507, Boston, MA 02118, USA
J Pharmacol Exp Ther 312:1144-50. 2005..This results in modest changes in platelet function and seems to be consistent with previous oncological studies demonstrating tamoxifen-dependent increase in reactive oxygen species generation...
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular diseasePeter J Mason
Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA, USA
Am J Cardiol 96:1365-9. 2005..In conclusion, our data demonstrate the complex nature of CD40L and highlight the distinct processes of expression, shedding, and clearance of this ligand in patient populations...
Compensatory mechanisms influence hemostasis in setting of eNOS deficiencyMark D Iafrati
Tufts New England Medical Center, 750 Washington Street, Boston, MA 02111, USA
Am J Physiol Heart Circ Physiol 288:H1627-32. 2005..Such compensatory mechanisms may partially explain the lack of spontaneous thrombosis, minimally elevated baseline blood pressure, and normal life span that are seen in animals deficient in a pivotal regulator of vascular patency...
Facts and controversies of aspirin and clopidogrel therapyDavid P Faxon
Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
Am Heart J 157:412-22. 2009..Overall, despite the existing controversies, antiplatelet therapy with aspirin and/or clopidogrel remains a proven and essential therapeutic tool for safe and effective management of atherothrombotic risk in specific clinical settings...
Aspirin resistance in atherosclerosisPrice Blair
Boston University School of Medicine, 700 Albany Street, W507, Boston, MA 02118, USA
Curr Atheroscler Rep 10:149-57. 2008..Due to the multifactorial nature of cardiovascular disease, it is likely that a single therapy like aspirin cannot fully treat and prevent all thrombotic complications in the setting of atherosclerosis...
The many antithrombotic actions of nitric oxideConstantine Tziros
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
Curr Drug Targets 7:1243-51. 2006..Recently, through the development of new NO donors and by targeting specific signaling pathways, there has been an attempt to enhance the antithrombotic actions of NO as a means to manipulate arterial thrombosis...
Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring StudyJohn F Keaney
Evans Memorial Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Am Heart J 156:1003-1009.e1. 2008..Circulating soluble CD40L (sCD40L) concentration predicts cardiovascular risk in selected patient samples. The purpose of this study was to determine the predictors of sCD40L in a large, community-based sample...
Aspirin resistance and atherothrombotic diseasePeter J Mason
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
J Am Coll Cardiol 46:986-93. 2005..Currently, however, there are many unanswered questions regarding the biological mechanism, diagnosis, population prevalence, clinical relevance, and optimal therapeutic intervention for aspirin resistance...
Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseasesElaine Lin
Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
Cardiovasc Ther 27:117-23. 2009..This article reviews the current experimental and clinical evidence for the role of TLRs in the cardiovascular system, and examines the mechanisms by which TLR antagonists could potentially be used in targeted therapy...
CD40-CD40L and platelet function: beyond hemostasisJane E Freedman
Circ Res 92:944-6. 2003
Regulation of endogenous reactive oxygen species in platelets can reverse aggregationPatricia Clutton
Department of Pharmacology, Georgetown University Medical Center, Washington, DC, USA
Arterioscler Thromb Vasc Biol 24:187-92. 2004..PI3-kinase plays a role in regulating NADPH oxidase-generated superoxide in platelets and, by altering the bioactivity of platelet NO, may be a potential method for reversing platelet aggregation and thrombus formation...
Platelet-monocyte aggregates: bridging thrombosis and inflammationJane E Freedman
Circulation 105:2130-2. 2002
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiolJose E Tanus-Santos
Division of Clinical Pharmacology, Georgetown University Medical School, Washington, DC, USA
Pharmacogenetics 12:407-13. 2002....
CD40 ligand--assessing risk instead of damage?Jane E Freedman
N Engl J Med 348:1163-5. 2003
Heritability, platelet function, and aspirin: a link established but cause unknownJane E Freedman
Circulation 115:2468-70. 2007
High-fat diets and cardiovascular disease: are nutritional supplements useful?Jane E Freedman
J Am Coll Cardiol 41:1750-2. 2003
Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug developmentNeal S Kleiman
Methodist DeBakey Heart Center, Houston, Texas, USA
Platelets 19:239-51. 2008....
Nitrated lipids: defining their bioactivityJane E Freedman
Circ Res 91:371-2. 2002
The antiinflammatory effects of purple grape juice consumption in subjects with stable coronary artery diseaseAnne R Albers
Arterioscler Thromb Vasc Biol 24:e179-80. 2004
The aspirin resistance controversy: clinical entity or platelet heterogeneity?Jane E Freedman
Circulation 113:2865-7. 2006
Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and CoJane E Freedman
Circulation 106:2623-9. 2002
Research Grants
- Gene Expression and Thrombosis in a Community Based Cohort StudyJane Freedman; Fiscal Year: 2007..Do changes in gene expression in platelets and leukocytes predict subclinical and clinical CVD? ..
- eNOS Polymorphisms, Aging and Platelet FunctionJane Freedman; Fiscal Year: 2005..We have continued to examine the imoortance of this mutation to the vascular response. ..
- PLATELET-DERIVED NITRIC OXIDE AND HEMOSTASISJane Freedman; Fiscal Year: 2003....
- Gene Expression and Thrombosis in a Community Based Cohort StudyJane E Freedman; Fiscal Year: 2010..Do changes in gene expression in platelets and leukocytes predict subclinical and clinical CVD? ..
